Analytical Method Comparability Studies: Expert Panel Discussion on Instrument and Technology Changes

This summary accompanies a recent expert forum discussion organised by BioQC, and we appreciate the panellists’ time and expertise.

This expert panel discussion explores practical approaches to comparability studies of analytical methods when transitioning between instruments or analytical technologies.

Comparability vs. Equivalence: Understanding the Terminology

Terminology proves critical when discussing method transitions, with “comparability,” “equivalence,” and “similarity” often used interchangeably despite having distinct meanings. Understanding these distinctions helps frame appropriate study objectives and acceptance criteria.

Equality represents the strictest concept—results from two methods would be exactly identical. When updating instruments or implementing new technologies, limiting studies to demonstrating exact equality proves unnecessarily restrictive. Exact equality prevents capturing improvements that new technology might offer, potentially blocking beneficial advances. Organisations should not constrain themselves to requiring new technology to perform exactly like old technology, as this eliminates opportunities for improvement.

Comparability provides a more appropriate framework for most method transitions. Comparable results mean obtaining the information needed from analytics across both methods, with results providing equivalent utility for decision-making. Comparability allows for improvements in performance characteristics. For example, chromatographic resolution might improve from one instrument to another, making results technically unequal whilst remaining comparable in their fitness for purpose. Resolution improvements can prove highly relevant in quality control departments, but improved data should be accepted rather than rejected for failing to match older, inferior performance.

This philosophy embraces technical improvements whilst ensuring continued fitness for intended use. Accepting improved data compared to historical data represents sound scientific practice, enabling organisations to benefit from technological advances rather than artificially constraining new methods to match the limitations of older systems.

Equivalence carries specific statistical connotations, generally understood as involving equivalence testing with associated hypothesis testing frameworks. Statistical equivalence testing employs specific methodologies examining whether methods fall within predetermined equivalence margins. This terminology implies particular statistical approaches that may not suit all comparability objectives.

Comparability offers greater openness regarding study conclusions. When comparing two instruments or methods, various outcomes become possible: concluding one is superior to another, identifying differences whilst characterising their nature, or demonstrating functional equivalence. This flexibility proves valuable because true values of measured attributes remain unknown. Both methods contain measurement error and likely exhibit bias. Statistical equivalence would require both methods having identical bias and identical precision—practically impossible when both measure with error.

Achieving true equivalence proves extremely difficult and may be confused with equivalence testing procedures. Comparability provides more realistic frameworks, offering room for improvement and acknowledging measurement uncertainty inherent in all analytical procedures. This distinction matters greatly for framing study objectives and selecting appropriate statistical methodologies.

Sample Selection Strategies: Representing Real-World Testing

Selecting appropriate samples for comparability studies requires careful consideration of what materials are routinely tested and which characteristics challenge methods most significantly. Sample selection strategies directly impact study informativeness and applicability to routine testing scenarios.

For instrument updates, examining materials regularly tested in quality control environments makes considerable sense. Selecting super-complex materials from external sources may seem scientifically rigorous, but it proves unnecessary if such materials do not represent actual routine testing situations. Studies should focus on what organisations actually do in daily business rather than artificially extreme scenarios. One effective strategy involves selecting the most complex sample affected by instrument changes.

Complexity can manifest in multiple ways: sample profiles with numerous peaks, particularly closely eluting peaks lacking baseline separation, challenging integration scenarios, or complex sample preparation procedures. Products with extensive peaks in close proximity provide rigorous tests of instrumental separation capability and data processing performance.

Sample preparation complexity also merits consideration. If sample preparation varies in complexity across products—involving more incubation steps, enzyme treatments, or other manipulations—these differences prove relevant because handling characteristics may differ between instruments. More complex sample preparation introduces additional variability sources and potential method-instrument interactions deserving attention.

Matrix effects require thoughtful assessment. The extent to which matrix components affect analytics should be understood, ideally from validation studies characterising matrix impacts. If certain components play relevant roles, examining differences across matrices makes sense. However, this does not necessitate double-checking everything or reinventing wheels. The principle depends heavily on specific methods and matrices involved.

For instrument comparisons specifically, focus should remain primarily on instrumental differences rather than matrix differences. The assumption that matrices should not substantially impact instrument performance itself proves reasonable for many applications, though this represents an assumption requiring verification through knowledge of instruments and technologies rather than exhaustive empirical testing of every possible matrix combination.

Distinguishing between addressing instrument differences versus analytical procedure differences proves critical. Studies should maintain appropriate focus—instrument comparability studies examine instrumental performance, not comprehensive procedural validation across all possible sample types. Maintaining this focus prevents scope creep whilst ensuring studies address their primary objectives.

Comprehensive Coverage: Designing Studies for Technology Comparisons

Different considerations apply when comparing fundamentally different technologies rather than similar instruments. Technology comparisonssuch as quantitative PCR measuring DNA inside viral particles versus capillary electrophoresis examining viral particles themselves—require comprehensive sample coverage spanning all situations likely encountered in practice.

From statistical perspectives, study designs must cover all possible situations that will occur during routine use. If specific factors critically affect method performance, these must be included in study designs. The key involves identifying which sample situations cause methods to perform differently regarding accuracy, precision, or other performance characteristics.

Complete matrix coverage proves less critical than having identical samples measured by both methods, ideally with replicates enabling assessment of whether methods perform equally across conditions and whether precision varies with concentration or other factors. Understanding how sample characteristics affect performance differences between methods provides actionable insights.

For example, sample purity during processing may affect methods differently. Understanding whether measured concentrations are affected by purity differences reveals whether methods measure identical analytes or different aspects affected by sample quality. This proves particularly important when technologies differ fundamentally, as they may respond to different molecular characteristics or sample properties.

The emphasis shifts from exhaustive matrix testing to strategic coverage ensuring relevant conditions are represented with appropriate replication. Having samples measured by both methods under conditions spanning the range of routine testing scenarios enables robust comparison whilst avoiding unnecessary complexity.

Continue Reading…

Register using the download form below to read the 10-page full summary (PDF) and meet the panel.

Would you like to read more summaries?